The results (Figure 4G–I) demonstrated that knockdown of IRF7 mitigated the death rate of BMSCs infected by S. aureus and E. coli, and a combined regimen of Fer‐1 and si‐Irf7 manifested pronounced synergistic anti‐ferroptosis effects in the context of both bacterial infections. This evidence concerns the gene IRF7 and bacterial infectious disease.